Vivanza Biosciences Limited has announced significant changes in its leadership and plans for business expansion following a board meeting held on November 11, 2025. The company, known for its biosciences operations, is planning to venture into the manufacturing and distribution of plastic polymer films and packaging materials.

Key Developments

Leadership Changes

The board has approved the following changes in the company's key personnel:

1. Appointment: CS Chaitra Arora has been appointed as the new Company Secretary and Compliance Officer, effective November 11, 2025. Arora brings experience in company law, SEBI regulations, and IPO due diligence to her new role.

2. Resignation: CS Siddhi Shah resigned from her position as Company Secretary and Compliance Officer, effective September 26, 2025, citing personal reasons and career advancement opportunities.

Business Expansion

Vivanza Biosciences is planning to diversify its operations by expanding into the plastic and packaging industry. The board has approved an alteration to the company's Memorandum of Association (MOA) to include:

• Manufacturing and processing of plastic polymer films
• Production of plastic and paper bags for packaging
• Distribution of flexible packaging materials for various industrial and consumer applications

This expansion is subject to shareholder approval through a postal ballot process.

Financial Performance

For the quarter ended September 30, 2025, Vivanza Biosciences reported:

Upcoming Shareholder Actions

The company has outlined the following timeline for the postal ballot process:

• Cut-off Date: November 7, 2025
• E-voting Period: November 17, 2025 (9 AM) to December 16, 2025 (5 PM)
• Results Declaration: By December 18, 2025

Market Implications

The planned expansion into plastic polymer films and packaging materials represents a significant diversification for Vivanza Biosciences. This move could potentially open new revenue streams for the company, aligning it with the growing demand for packaging solutions across various industries.

Investors and stakeholders will likely be closely watching how this expansion may impact the company's future financial performance and market position. The upcoming postal ballot will be crucial in determining the path forward for Vivanza Biosciences' diversification strategy.

As the company prepares for this potential new phase, the appointment of CS Chaitra Arora as Company Secretary and Compliance Officer is expected to play a vital role in navigating the regulatory landscape associated with this business expansion.

Vivanza Biosciences Limited , a company listed on the BSE, has announced several key developments in its recent board meeting held on November 11, 2025. The company has reported its quarterly results, made changes in key personnel, and proposed a significant alteration to its business objectives.

Financial Performance

The board of Vivanza Biosciences approved the unaudited financial results for the quarter ended September 30, 2025. The company reported:

These figures demonstrate the company's operational performance for the quarter, providing investors with insights into its financial health.

Changes in Key Personnel

New Company Secretary Appointment

The board, on recommendations from the Nomination and Remuneration Committee, has approved the appointment of CS Chaitra Arora as the new Company Secretary and Compliance Officer. CS Arora, holding membership number A78376, will take on this key managerial role effective November 11, 2025.

CS Arora brings experience in company law, SEBI regulations, and IPO due diligence to her new position. Her skills in drafting and practical knowledge of corporate governance, compliance, and regulatory filings are expected to be valuable assets to the company.

Previous Company Secretary's Resignation

This appointment follows the resignation of CS Siddhi Shah (Membership number A44885) from the position of Company Secretary & Compliance Officer. CS Shah's resignation, effective from September 26, 2025, was attributed to personal reasons and career advancement opportunities.

Proposed Business Expansion

The board has approved an alteration to the company's main object clause in its Memorandum of Association (MOA). This proposed change aims to expand Vivanza Biosciences' business scope to include:

• Manufacturing, processing, producing, and dealing in plastic polymer films
• Production of plastic bags and sacks from various polymers
• Manufacturing paper bags for packaging
• Developing flexible packaging materials for diverse applications

This expansion, if approved by shareholders, would mark a strategic diversification for the company, potentially opening up new revenue streams in the packaging industry.

Shareholder Approval Process

The company has initiated a postal ballot process to seek shareholder approval for the proposed alteration in the MOA. Key dates for this process include:

• Cut-off date for shareholder eligibility: November 7, 2025
• E-voting period: November 17, 2025 (9:00 AM) to December 16, 2025 (5:00 PM)
• Results declaration: By December 18, 2025

Mr. Chintan K. Patel, a Practicing Company Secretary, has been appointed as the scrutinizer for the e-voting process.

These developments indicate that Vivanza Biosciences is taking steps to strengthen its corporate governance and explore new business opportunities. Shareholders and potential investors should closely monitor these changes and their potential impact on the company's future performance and market position.